Sarcoma tumor FDG uptake measured by PET and patient outcome: A retrospective analysis

European Journal of Nuclear Medicine

Volumn 29, Issue 9, 2002, Pages 1149-1154

  Eary, Janet F ^a,b   O'Sullivan, Finbarr ^a,b   Powitan, Yudi ^a,b   Chandhury, Kingshuk ^a,b   Vernon, Cheryl ^a,b   Bruckner, James D ^a,b   Conrad, Ernest U ^a,b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b University College   (Ireland)

Author keywords

Disease free interval; FDG PET; Sarcoma; Survival; SUVmax

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DRUG UPTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; SARCOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; BONE NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0036367410     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0859-5     Document Type: Article

References (13)

1. Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pre-treatment and grading of sarcoma
2. Metabolic imaging of human extremity musculoskeletal tumors by PET
3. PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose
4. Tumor metabolic rates in sarcoma using FDG PET
5. Noninvasive grading of musculoskeletal tumors using PET
6. Fluorine-18-fluorodeoxy-glucose PET imaging of soft-tissue sarcoma
7. Fluorodeoxy-glucose positron emission tomography of soft tissue tumors: Is a non-invasive determination of biological activity possible?
8. Grading of tumors and tumorlike lesions of bone: Evaluation by 2-(fluorine-18)-fluoro-2deoxy-D-glucose positron emission tomography
9. (F-18)fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma
10. Investigation of the count rate performance of the General Electric ADVANCE positron emission tomograph
11. Nonparametric estimation from incomplete observations
12. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with non-small cell lung carcinoma